Evista
Raloxifene hydrochloride
- Strength
- 60 mg/1
- Form
- Tablet
- Class
- Estrogen Agonist/Antagonist
Eli Lilly and Company
Listed by A-S Medication Solutions
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Estrogen Agonist/Antagonist |
| Approval route | ANDA — approved generic |
| NDC code | 50090-7073 |
| FDA application | ANDA204310 |
| RxNorm concept | 1490065 |
| Package sizes listed | 1 |
| Marketed since | August 2015 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Raloxifene hydrochloride
Eli Lilly and Company
Modavar Pharmaceuticals LLC
NorthStar Rx LLC
AvPAK
Amneal Pharmaceuticals LLC
Glenmark Pharmaceuticals Inc., USA
Exelan Pharmaceuticals, Inc.
Raloxifene
Cipla USA Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.